Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-28

Clinical Trial Update: Optimal Treatment Strategy Based on for Pediatric AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating optimal treatment strategies for pediatric acute myeloid leukemia, sponsored by Samsung Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samsung Medical Center | Conditions: Pediatric Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN